.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Plenary Session

Plenary session 2
Vaccines

Termin

Datum: 26.03.2024

Zeit: 08:30 – 10:00

Ort / Stream:

Lecture hall 1

Chair

Programm

08:30 – 09:00 25 Min. 5 Min.
Plenary talk
PT 04
Impact of structural dynamics on flavivirus-antibody interactions
Professor Karin Stiasny (Wien / AT)
09:00 – 09:30 25 Min. 5 Min.
Plenary talk
PT 05
Broadly neutralizing HIV-1antibodies: Lone superstars or team players?
Prof. Dr. Alexandra Trkola (Zurich / CH)
09:30 – 10:00 25 Min. 5 Min.
Plenary talk
PT 06
Development of broadly protective influenza virus vaccines
Professor Florian Krammer (New York, NY / US)

Plenary session 2Vaccines

Termin

Chair

Programm

Plenary session 2
Vaccines